Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.36
-0.01 (-0.19%)
Jul 31, 2026, 3:56 PM HKT

HKG:2566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
138.41138.6119.7859.87119.41
Depreciation & Amortization
37.9136.2235.8235.7724.24
Other Amortization
6.660.720.32--
Loss (Gain) From Sale of Assets
0.070.270.410.040.33
Loss (Gain) From Sale of Investments
2.836.51.220.46-0.08
Stock-Based Compensation
5.555.311.930.180.15
Other Operating Activities
-4.3326.2426.6212.747.24
Change in Accounts Receivable
23.57-144.3-62.47-82.03-131.24
Change in Inventory
-6.9911.390.9127.7949.16
Change in Accounts Payable
21.38-15.42-9.22-14.8-32.69
Change in Unearned Revenue
-0.997.59-2.15-5.031.19
Change in Other Net Operating Assets
30.7921.6812.61-12.4129.83
Operating Cash Flow
254.8494.79135.7722.5667.53
Operating Cash Flow Growth
168.86%-30.19%501.82%-66.59%-

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-49.59-15.09-21.1-23.3-53.94
Sale of Property, Plant & Equipment
0.080.1200.010.05
Sale (Purchase) of Intangibles
-55.06-64.76-25.88-35.66-8.97
Investment in Securities
-300----
Investing Cash Flow
-404.57-79.73-46.98-58.94-62.86

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
114.9130.2143.31204.17209.62
Long-Term Debt Repaid
-136.07-176.55-196.16-170.3-158.65
Net Debt Issued (Repaid)
-21.17-46.35-52.8633.8850.97
Issuance of Common Stock
-521---
Common Dividends Paid
-13.73---12-
Other Financing Activities
-4.54-46.34-14.49-8.98-9.75
Financing Cash Flow
-39.45428.32-67.3512.8941.23

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.221.080.210.2-0.12
Net Cash Flow
-188.96444.4521.64-23.2945.78

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
205.2579.69114.66-0.7413.59
Free Cash Flow Growth
157.56%-30.50%---
Free Cash Flow Margin
15.71%5.82%8.91%-0.07%1.04%
Free Cash Flow Per Share
0.840.390.57-0.000.07
Levered Free Cash Flow
83.8514.9112.11-51.21-
Unlevered Free Cash Flow
87.3919.3717.98-45.56-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.57.159.418.989.75
Cash Income Tax Paid
31.3719.16-1.1-10.511.74
Change in Working Capital
67.76-119.06-60.32-86.5-83.76